ReportGem ReportGem

GLOBAL RESEARCH ARCHIVE

Healthpeak Properties Inc: 2Q26 earnings: Core FFO above cons; 26e guide raised above cons; KPIs improving; generated $1.4B in proceeds; lab recovery in focus

Published: 2026-08-05Institution: Morgan StanleyCompany / ticker: DOC.NPages: 11Original language: 英语

Research evidence excerpt

M

Update

August 5, 2026 03:16 AM GMT

Healthpeak Properties Inc | North America

Morgan Stanley & Co. LLC

Ronald Kamdem, CFA

Equity Analyst

2Q26 earnings: Core FFO above

cons; 26e guide raised above

cons; KPIs improving; generated

$1.4B in proceeds; lab recovery

in focus

Derrick Metzler

Research Associate

Adam Kramer

Equity Analyst

Healthpeak Properties Inc (DOC.N, DOC UN)

Real Estate Investment Trusts | United States of America

Stock Rating

Industry View

Price target

Shr price, close (Aug 4, 2026)

Mkt cap, curr (mm)

52-Week Range

Equal-weight

In-Line

$22.00

$21.62

$15,341

$22.95-15.71

AlphaSignals Earnings Reaction

Unchanged

Modest upside

Modest revision higher

Impact to our thesis

Financial results versus consensus

Direction of next 12-month

consensus EPS

Source: Company data, Morgan Stanley Research

Key Takeaways

2Q core FFO of $0.46 vs cons/MSe $0.43; 2Q Total Portfolio SS-NOI was +1.8%

YoY (vs +0.0% in 1Q);

SS-NOI for Lab of -3.2% (vs. -7. 2% in 1Q); Outpatient Medical of +2.5% (vs. +2.4%

in 1Q) and Senior Housing +19.2% (vs. +13.8% in 1Q)

26e guide raised +$0.02 to $1.75 vs. cons $1.74/MSe $1.73; 26e Total Portfolio SSNOI guide raised +75bps to 0.75%

Net Debt to Adjusted EBITDAre was 4.7x vs 5.4x in 1Q; div $0.31 (flat YoY and

QoQ)

Generated ~$1.4 billion of proceeds: $2.1B Brookfield JV ($1.025B proceeds),

$400mn proceeds from seller financing repayment, and a $40mn non-core OM

sale.

Additional Takeaways:

• What's our view? We expect a positive stock price reaction to 2Q core FFO

above cons, improving KPIs and 26e core FFO guidance raised above

consensus. Capital recycling is a big focus as the previously announced

Brookfield JV left the company with ~$1.025B of proceeds at a 5.9% implied

cap rate, which were used to replay $650 million of 3.25% senior notes and

$375 million of 4.14% commercial paper, implying modest dilution, but

addressing significant maturities and resulting in -0.7x lower leverage q/q.

Additionally, DOC entered into a development agreement for a new $20

million OM building in Atlanta that is 84% pre-leased to Northside Hospital

and affiliated physician groups. Our conversations with the company

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer